Nucleotide and amino acid sequences encoding an exported protein 1 derived from Plasmodium vivax and uses thereof

• US 8,318,897 B2
• Filed: 08/29/2011
• Issued: 11/27/2012
• Est. Priority Date: 03/27/2009
• Status: Active Grant

• Current Assignee: Abbott Laboratories Incorporated
• Original Assignee: Abbott Laboratories Incorporated
• Inventors: Birkenmeyer, Larry G., Coffey, Ruthie E., Dawson, George J., Desai, Suresh M., Dille, Bruce J., Muerhoff, Anthony Scott
• Primary Examiner(s): Minnifield, Nita M
• Assistant Examiner(s): Gangle, Brian J
• Application Number:
  US13/219,802
• Publication Number:
  US 20110311572A1
• Time in Patent Office: 456 Days
• Field of Search: None
• US Class Current: 530/324
• CPC Class Codes: A61K 39/00 Medicinal preparations containing antigens or antibodies materials for immunoassay G01N33/53
• CPC Class Codes: A61P 33/02 Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
• CPC Class Codes: A61P 37/04 Immunostimulants
• CPC Class Codes: C07K 14/445 Plasmodium
• CPC Class Codes: G01N 2333/445 Plasmodium
• CPC Class Codes: G01N 33/56905 Protozoa
• CPC Class Codes: Y02A 50/30 Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The present invention is directed to novel polynucleotides and polypeptides directed to EXP1 of Plasmodium vivax, and methods of using these polynucleotides and polypeptides in the detection of P. vivax antibodies or anti-P. vivax antibodies in a subject. The invention finds particular useful application in identifying recent exposure to P. vivax.

Claims

1. A purified protein encoded by a nucleic acid, wherein said nucleic acid comprises a nucleotide sequence encoding a polypeptide, wherein the amino acid sequence of said polypeptide has at least 70% identity to an amino acid sequence selected from the group consisting of SEQ ID NO:

2, SEQ ID NO;

3 and amino acids 2-50 of SEQ ID NO;

2.

2. A purified protein comprising an amino acid sequence having at least 70% identity to an amino acid sequence selected from the group consisting of SEQ ID NO:

2, SEQ ID NO;

3, and amino acids 2-50 of SEQ ID NO;

2.

3. A kit for determining the presence of antibody to P. vivax in a test sample comprising:

(a) an antigen comprising an amino acid sequence selected from the group consisting of SEQ ID NO;

2, SEQ ID NO;

3, and amino acids 2-50 of SEQ ID NO;

2; and

(b) a conjugate comprising an antibody attached to a signal-generating compound capable of generating a detectable signal.

4. A kit for determining the presence of antibody to P. malariae, P. ovale, P. vivax and P. falciparum in a test sample comprising:

(a) an antigen comprising an amino acid sequence selected from the group consisting of SEQ ID NO;

2, SEQ ID NO;

3, and amino acids 2-50 of SEQ ID NO;

2, a P. ovale, a P. malariae antigen and a P. falciparum antigen; and

(b) a conjugate comprising an antibody attached to a signal generating compound capable of generating a detectable signal.

5. A kit for detecting antibodies to P. malariae, P. ovale, P. vivax and P. falciparum in a test sample comprising:

(a) an anti-antibody; and

(b) an antigen comprising an amino acid sequence selected from the group consisting of SEQ ID NO;

2, SEQ ID NO;

3, and amino acids 2-50 of SEQ ID NO;

2, a P. ovale antigen, a P. malariae antigen and a P. falciparum antigen.

6. A kit for detecting antibodies to P. malariae, P. ovale, P. vivax and P. falciparum in a test sample comprising:

(a) an anti-antibody and

(b) a first conjugate comprising an antigen comprising an amino acid sequence selected from the group consisting of SEQ ID NO;

2, SEQ ID NO;

3, and amino acids 2-50 of SEQ ID NO;

2, attached to a signal generating compound capable of generating a detectable signal, a second conjugate comprising a P. ovale antigen;

a third conjugate comprising a P. malariae antigen attached to a signal generating compound capable of generating a detectable signal and a fourth conjugate comprising a P. falciparum antigen attached to a signal generating compound capable of generating a detectable signal.

7. A method of detecting antibodies to P. vivax in a test sample suspected of containing the antibodies comprising the steps of

(a) contacting the test sample with an antigen comprising an amino acid sequence selected from the group consisting of SEQ ID NO:

2, SEQ ID NO;

3, and amino acids 2-50 of SEQ ID NO;

2, for a time and under conditions sufficient for the formation of antibody/antigen complexes; and

(b) detecting the presence of antibodies present in the test sample by detecting presence of the antibody/antigen complexes.

8. A method of detecting antibodies to P. vivax in a test sample suspected of containing the antibodies comprising the steps of:

(a) contacting the test sample with an antigen comprising an amino acid sequence selected from the group consisting of SEQ ID NO;

2, SEQ ID NO;

3, and amino acids 2-50 of SEQ ID NO;

2, for a time and under conditions sufficient to allow for the formation of antibody/antigen complexes;

(b) adding a conjugate to resulting antibody/antigen complexes for a time and under conditions sufficient to allow the conjugate to bind to bound antibody, wherein the conjugate comprises an antibody attached to a signal generating compound capable of generating a detectable signal; and

(c) detecting the presence of antibodies present in the test sample by detecting presence of the signal generated by the signal generating compound.

9. A method of detecting antibodies to P. vivax in a test sample suspected of containing the antibodies comprising the steps of:

(a) contacting the test sample with an antigen comprising an amino acid sequence selected from the group consisting of SEQ ID NO;

2, SEQ ID NO;

3, and amino acids 2-50 of SEQ ID NO;

2, for a time and under conditions sufficient to allow for the formation of antibody/antigen complexes;

(b) adding a conjugate to resulting antibody/antigen complexes for a time and under conditions sufficient to allow the conjugate to bind to bound antibody, wherein the conjugate comprises an antigen comprising an amino acid sequence selected from the group consisting of SEQ ID NO;

2, SEQ ID NO;

3, and amino acids 2-50 of SEQ ID NO;

2, attached to a signal generating compound capable of generating a detectable signal; and

(c) detecting the presence of antibodies present in the test sample by detecting presence of the signal generated by the signal generating compound.

10. A method of detecting the presence of P. vivax antibodies in a test sample suspecting of containing the antibodies comprising the steps of:

(a) contacting the test sample with anti-antibody for a time and under conditions sufficient to allow for formation of anti-antibody/P. vivax antibody complexes;

(b) adding antigen to the resulting anti-antibody/P. vivax antibody complexes for a time and under conditions sufficient to allow the antigen to bind to bound antibody, wherein the antigen comprises an amino acid sequence selected from the group consisting of SEQ ID NO;

2, SEQ ID NO;

3, and amino acids 2-50 of SEQ ID NO;

2;

(c) adding a conjugate to the resulting anti-antibody/P. vivax antibody/antigen complexes, wherein the conjugate comprises a composition comprising a monoclonal or polyclonal antibody attached to a signal generating compound capable of generating a detectable signal; and

(d) detecting presence of antibodies which can be present in the test sample by detecting presence of the signal generated by the signal generating compound.

11. A method of detecting antibodies to P. malariae, P. falciparum, P. vivax and P. ovale in a test sample suspected of containing at least one of the antibodies comprising the steps of:

(a) contacting the test sample with;

(i) an antigen comprising an amino acid sequence selected from the group consisting of SEQ ID NO;

2, SEQ ID NO;

3, and amino acids 2-50 of SEQ ID NO;

2, (ii) an antigen from P. falciparum;

(iii) an antigen from P. ovale, and (iv) an antigen from P. malariae, for a time and under conditions sufficient for the formation of P. malariae antibody/antigen complexes, P. falciparum antibody/antigen complexes, P. vivax antibody/antigen complexes and P. ovale antibody/antigen complexes; and

(b) detecting the presence of antibodies present in the test sample by detecting presence of one or more of the complexes.

12. A method of detecting antibodies to P. malariae, P. ovale, P. vivax and P. falciparum in a test sample suspected of containing at least one of the antibodies comprising the steps of:

(a) contacting the test sample with;

(i) an antigen comprising an amino acid sequence selected from the group consisting of SEQ ID NO;

2, SEQ ID NO;

3, and amino acids 2-50 of SEQ ID NO;

2, (ii) a P. ovale antigen, (iii) a P. malariae antigen and (iv) a P. falciparum antigen, for a time and under conditions sufficient to allow for the formation of P. malariae antibody/antigen complexes, P. ovale antibody/antigen complexes, P. vivax antibody/antigen complexes and P. falciparum antibody/antigen complexes;

(b) adding four conjugates to the resulting antibody/antigen complexes for a time and under conditions sufficient to allow each conjugate to bind to bound antibody, wherein a first conjugate comprises an antigen comprising an amino acid sequence selected from the group consisting of SEQ ID NO;

2, SEQ ID NO;

3, and amino acids 2-50 of SEQ ID NO;

2, attached to a signal generating compound capable of generating a detectable signal;

a second conjugate comprises if P. ovale antigen attached to a signal generating signal capable of generating a detectable signal;

a third conjugate comprises a P. malariae antigen attached to a signal generating signal capable of generating a detectable signal and a fourth conjugate comprises a P. falciparum antigen attached to a signal generating compound capable of generating a detectable signal; and

(c) detecting the presence of antibody to P. malariae, P. ovale, P. vivax and P. falciparum which can be present in the test sample by detecting presence of the signal generated by the signal generating compound.

13. A method of detecting antibodies to P. malariae, P. ovale, P. vivax and P. falciparum in a test sample suspected of containing at least one of the antibodies comprising the steps of:

(a) contacting the test sample with (i) an antigen comprising an amino acid sequence selected from the group consisting of SEQ ID NO;

2, SEQ ID NO;

3, and amino acids 2-50 of SEQ ID NO;

2, (ii) P. malariae antigen, (iii) a P. vivax antigen and (iv) a P. falciparum antigen, for a time and under conditions sufficient to allow for the formation of P. malariae antibody/antigen complexes, P. ovale antibody/antigen complexes, P. vivax antibody/antigen complexes and P. falciparum antibody/antigen complexes;

(b) adding a conjugate to the resulting antibody/antigen complexes for a time and under conditions sufficient to allow each conjugate to bind to bound antibody, wherein the conjugate comprises an antibody attached to a signal generating compound capable of generating a detectable signal; and

(c) detecting the presence of antibody to P. malariae, P. ovale, P. vivax and P. falciparum antibody which can be present in the test sample by detecting presence of the signal generated by the signal generating compound.

14. A method for detecting the presence of antibodies to P. malariae, P. ovale, P. vivax and P. falciparum in a test sample suspected of containing at least one of the antibodies comprising the steps of:

(a) contacting the test sample with anti-antibody for a time and under conditions sufficient to allow for formation of anti-antibody/P. vivax, anti-antibody/P. malariae, anti-antibody/P. ovale, and anti-antibody/P. falciparum complexes;

(b) adding a first antigen, a second antigen, a third antigen, and a fourth antigen to the resulting anti-antibody/P. vivax, anti-antibody/P. malariae, anti-antibody/P. ovale, and anti-antibody/P. falciparum complexes for a time and under conditions sufficient to allow the antigens to bind to bound antibody, wherein (i) the first antigen comprises an amino acid sequence selected from the group consisting of SEQ ID NO;

2, SEQ ID NO;

3, and amino acids 2-50 of SEQ ID NO;

2;

(ii) the second antigen comprises a P. ovale antigen;

(iii) the third antigen comprises a P. malariae antigen; and

(iv) the fourth antigen comprises a P. falciparum antigen;

(c) adding a first conjugate, a second conjugate, a third conjugate and a fourth conjugate to the resulting anti-antibody/antibody/antigen complexes for a time and under conditions sufficient to allow the conjugates to bind to bound antibody, wherein the conjugates are each attached to a signal generating compound capable of generating a detectable signal; and

(i) the first conjugate comprises a composition comprising a monoclonal or polyclonal antibody raised against P. vivax antibody/antigen complexes;

(ii) the second conjugate comprises a composition comprising a monoclonal or polyclonal antibody raised against P. ovale antibody/antigen complexes;

(iii) the third conjugate comprises a composition comprising a monoclonal or polyclonal antibody raised against P. malariae antibody/antigen complexes;

(vi) the fourth conjugate comprises a composition comprising a monoclonal or polyclonal antibody raised against P. falciparum antibody/antigen complexes; and

(d) detecting presence of antibodies which can be present in the test sample by detecting presence of the signal generated by the signal generating compounds.

15. A method for detecting the presence of antibodies to P. malariae, P. ovale, P. vivax and P. falciparum in a test sample suspected of containing at least one of the antibodies comprising the steps of

(a) contacting the test sample with anti-antibody to allow for the formation of anti-antibody/antibody complexes;

(b) adding a first conjugate, a second conjugate, a third conjugate and a fourth conjugate to resulting anti-antibody/antibody complexes for a time and under conditions sufficient to allow the conjugates to bind to bound antibody, wherein the first conjugate comprises an antigen comprising an amino acid sequence selected from the group consisting of SEQ ID NO;

2, SEQ ID NO;

3, and amino acids 2-50 of SEQ ID NO;

2, attached to a signal generating compound capable of generating a detectable signal, wherein the second conjugate comprises a P. ovale antigen attached to a signal generating compound capable of generating a detectable signal, wherein the third conjugate comprises a P. vivax antigen attached to a signal generating compound capable of generating a detectable signal, and wherein the fourth conjugate comprises a P. falciparum antigen attached to a signal generating compound capable of generating a detectable signal; and

(c) detecting the presence of antibodies to P. malariae, P. ovate, P. vivax and P. falciparum in the test sample by detecting presence of the signal generated by the signal generating compound.

16. A method of detecting the presence of P. vivax antibodies in a test sample suspected of containing the antibodies comprising the steps of

(a) contacting the test sample with anti-antibody for a time and under conditions sufficient to allow for formation of anti-antibody/P. vivax antibody complexes;

(b) adding antigen to the resulting anti-antibody/P. vivax antibody complexes for a time and under conditions sufficient to allow the antigen to bind to bound antibody, wherein the antigen comprises an amino acid sequence selected from the group consisting of SEQ ID NO;

2, SEQ ID NO;

3, and amino acids 2-50 of SEQ ID NO;

2, wherein the antigen is conjugated to a signal generating compound capable of generating a detectable signal; and

(c) detecting presence of antibodies which can be present in the test sample by detecting presence of the signal generated by the signal generating compound.